Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Archer | 2025 | Post Ipo Equity | $650.0M | San Francisco |
| Affirm | 2025 | Post Ipo Debt | $750.0M | San Francisco |
| Tabby | 2025 | Secondary Market | Undisclosed | Riyadh |
| Nurix Therapeutics | 2025 | Post Ipo Equity | $250.0M | San Francisco |
| Tubulis | 2025 | Series C | $400.6M | Munich |
| Kin Insurance | 2025 | Debt Financing | $45.0M | Chicago |
| Zenas BioPharma | 2025 | Post Ipo Equity | $120.0M | Waltham |
| Judi Health | 2025 | Series F | $252.0M | New York |
| Avidity Biosciences | 2025 | Post Ipo Equity | $690.0M | San Diego |
| Porter | 2025 | Series Unknown | $25.0M | Bangalore |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 126 | Archer | Post Ipo Equity | $650.0M | San Francisco, United States |
| 127 | Affirm | Post Ipo Debt | $750.0M | San Francisco, United States |
| 128 | Tabby | Secondary Market | Undisclosed | Riyadh, Saudi Arabia |
| 129 | Nurix Therapeutics | Post Ipo Equity | $250.0M | San Francisco, United States |
| 130 | Tubulis | Series C | $400.6M | Munich, Germany |
| 131 | Kin Insurance | Debt Financing | $45.0M | Chicago, United States |
| 132 | Zenas BioPharma | Post Ipo Equity | $120.0M | Waltham, United States |
| 133 | Judi Health | Series F | $252.0M | New York, United States |
| 134 | Avidity Biosciences | Post Ipo Equity | $690.0M | San Diego, United States |
| 135 | Porter | Series Unknown | $25.0M | Bangalore, India |
Archer is an aerospace company that developed an electric vertical takeoff and landing aircraft tailored for urban air mobility systems.
Affirm is a financial technology services company that offers installment loans to consumers at the point of sale.
Tabby is a payments and shopping app that enables customers to make purchases and pay for them in installments.
Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.
Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications.
Kin Insurance is a direct-to-consumer digital insurance provider that enhances convenience and customization in coverage options.
Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.
Judi Health is a healthtech platform that provides pharmacy benefit management solutions.
Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.
Porter offers logistics service solutions designed to help businesses streamline and optimize their last-mile delivery operations.
Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.
Swept AI is a software company that provides AI applications tool, compliance infrastructure and security services.
BBOT is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapeutics targeting RAS and PI3Kα malignancies.
Coinbase is a crypto exchange and wallet platform that allows merchants and consumers to buy, sell, and store digital currencies.
Vanta is a trust management platform that automates compliance and risk management.
EVgo provides fast charging networks for private and public electric vehicles.
Scale AI provides a data-oriented platform that assists in the development of AI applications.
FalconX is a digital assets prime brokerage providing trading, financing, and custody services.
Omada Health is a digital behavioral medicine company that helps members change their mindsets to improve health and build lasting change.
Warby Parker is a lifestyle brand that offers designer eyewear while being a socially conscious business.
Porch Group is a vertical software platform for residential environments.
Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.
AssetWatch is a deployable, remote, end-to-end condition monitoring solution providing predictive insight to enable proactive maintenance.
Maza is a mobile app that offers financial products and digital banking services.
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Wellington Management has invested in 228 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Wellington Management's top investment sectors include Health Care, Biotechnology, Therapeutics, Pharmaceutical, Financial Services. The firm invests across 60 different industry categories.
Among tracked funding rounds, Scale received $14.3B in a Corporate Round round. Wellington Management's total known invested capital is $36.2B.
Wellington Management's average investment size is $283.1M across its portfolio of 228 companies.
Recent Wellington Management portfolio additions include Archer, Affirm, Tabby, Nurix Therapeutics, Tubulis. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors